Pallas vs AltRx: GLP-1 Telehealth Compared

AltRx advertises some of the deepest promotional pricing in GLP-1 telehealth — compounded semaglutide from $89/month during its current promotion, with multi-month tiers going lower. Pallas Health takes the opposite pricing posture: a higher sticker with the entire arc — intro, renewal, interval — printed in one sentence. This comparison is really about promotional pricing versus published pricing, and the refund terms underneath each.

This is an honest comparison. AltRx's promotions rotate on short windows, so figures reflect published pricing as of August 2026 — confirm current numbers on both sites before signing up.

The three differences that matter most

1. Promo price versus published price. AltRx's $89/month semaglutide and $149/month tirzepatide are promotional rates shown against struck-through list prices of $199 and $299; its multi-month prepay tiers run lower still. What the price becomes at renewal isn't separately published. Pallas's number is the published number: $139 for your first month, then $597 every 12 weeks ($199/mo average). Cancel anytime. Tirzepatide injection is $179 for your first month, then $897 every 12 weeks ($299/mo average). Cancel anytime. With any promotional offer — anywhere — get the renewal rate in writing before you enroll.
2. The refund window. Per AltRx's published policy, medication orders are non-refundable once your intake is submitted; refunds apply only to provider-determined medical ineligibility or verified billing errors, and requests must be filed within 28 days of payment. Pallas refunds in full if a clinician decides treatment isn't right for you, and you can cancel your plan anytime, self-serve.
3. Track record. AltRx is a very young consumer brand — its Better Business Bureau file opened in May 2026 and the company publishes no founding history. Pallas is young too (founded 2026) — the difference is verifiability: Pallas is LegitScript Healthcare Merchant Certified, checkable in LegitScript's public database, with named clinical leadership on its site.

Pallas offers both FDA-approved and compounded medications. Compounded medications are not FDA-approved and are not generic versions of brand-name drugs. Eligibility and treatment are determined by a US-licensed clinician; results vary. Private pay only (no insurance). Operated by Brentmoor, Inc.

Quick comparison

What AltRx does well

The lowest promo numbers in the category. During its current promotion, $89/month semaglutide — and $75/month on a 12-month prepay — undercut essentially everyone, including Pallas. Shipping is free, there's no membership fee, and it advertises flat pricing across doses. If the promotional number holds at renewal, it's a genuinely cheap program; confirm that in writing.

Named 503A pharmacy partners. AltRx lists its compounding pharmacy partners on its product pages — a transparency point in its favor.

What Pallas does differently

Published pricing you can hold us to. Every Pallas surface states the intro, the renewal amount, the interval, and the per-month average in one sentence — $139 for your first month, then $597 every 12 weeks ($199/mo average). Cancel anytime. — flat at every dose. No struck-through list prices, no time-boxed banners, no checkout reveal.

The stronger refund posture. Full refund if a clinician doesn't prescribe. Cancel anytime, no windows to hit, no 28-day filing deadline. If your plans change, the terms work in your favor rather than against the clock.

Verifiability. Pallas is LegitScript Healthcare Merchant Certified — confirm it yourself in LegitScript's public database — with a self-serve portal, anytime provider messaging, and the free Pallas companion app (iOS and Android). Whatever platform you consider, run the same checks: LegitScript status, clinician licensure in your state, and US-licensed pharmacy sourcing.

Brand-name breadth. Pallas dispenses all four FDA-approved GLP-1 brands cash-pay from $1,069/month — below AltRx's listed brand prices — with no membership on any tier.

Who should pick which

AltRx may fit if:

• The promotional price is your deciding factor and you've confirmed, in writing, what renewal costs
• You're comfortable with orders being non-refundable once your intake is submitted

Pallas is probably the better fit if:

• You want the ongoing price published before you start — and flat at every dose
• You want a full refund if a clinician doesn't prescribe, and cancel-anytime terms
• Verifiable certification and named clinical leadership matter to your decision
• You may want brand-name medication at the lower cash price

Switching between them

Bring your medication name, current dose, and titration history. A Pallas clinician picks up from your current dose — no restart of titration unless you've been off medication for more than four weeks. For the clinical side of choosing between molecules, see semaglutide vs tirzepatide.

References

Platform pricing and program details reflect each company's publicly published terms as of August 2026 and change frequently — AltRx's promotions in particular rotate on short windows. Confirm current numbers on each platform's site before enrolling.

1. AltRx. Compounded semaglutide and refund and cancellation policy, as published August 2026.
2. U.S. Food and Drug Administration. Warning letter to Trinity HealthCare Supply, LLC dba altRx (MARCS-CMS 728236). June 8, 2026.
3. U.S. Food and Drug Administration. FDA Clarifies Policies for Compounders as National GLP-1 Supply Begins to Stabilize. 2025.

Bottom line: AltRx competes on the promotional number — the deepest in the category right now — with refund terms that close once your intake is submitted and a consumer track record that's only months old. Pallas competes on the published number: the full price arc stated up front, flat at every dose, full refund if a clinician doesn't prescribe, cancel anytime, verifiable certification, and cheaper brand-name access. Decide which of those two postures you want to buy healthcare from — and whichever you pick, get the renewal rate in writing.